Total: 8 |
|
PMID (PMCID) | ||
---|---|---|
30906603 |
OTHER | |
Castleman Disease in a Patient with Common Variable Immunodeficiency. | ||
Ricciardi L, Furci F, Ieni A, Macri A. Case Reports Immunol. 2019;2019:5476383. |
||
Castleman disease (CD) is a systemic disease clinically characterized by diffuse lymphadenopathy, splenomegaly, anemia, and systemic inflammatory symptoms. | ||
29626596 |
OTHER | |
Renal histology in a patient with TAFRO syndrome: a case report. | ||
Mizuno H, Sekine A, Oguro M, Oshima Y, Kawada M, Sumida K, Yamanouchi M, Hayami N, Suwabe T, Hiramatsu R, Hasegawa E, Hoshino J, Sawa N, Fujii T, Takaichi K, Ohashi K, Ubara Y. Hum Pathol. 2018;82:258-263. |
||
Autopsy showed hyaline vascular-type Castleman disease-like lymphadenopathy and reticulin myelofibrosis with an increase of megakaryocytes. | ||
29668470 |
MALE | Middle Aged |
Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer. | ||
Petrusevska M, Stavridis IP, Mladenovska K, Petrushevska G. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017;38(3):97-103. |
||
After four years of treatment with the combined chemotherapy, the patient presented inguinal lymphadenopathy and enlarged lymph nodes and histopathology rapport was suggestive for plasmacytoid variant of Castleman disease. | ||
26490523 |
FEMALE | Middle Aged |
Multicentric Castleman Disease with Monoclonal Incomplete IgH Restriction: A Rare Coexistence. | ||
Goyal G, Kendric K, Silberstein PT, Caponetti GC, Vivekanandan R. J Clin Exp Hematop. 2015;55(2):103-8. |
||
As treatment for Castleman disease, she was administered a combination of rituximab and etoposide, which led to a reduction in lymphadenopathy. | ||
24048114 (4391510) |
MALE | Adult |
Diffuse lymphadenopathy as the presenting manifestation of systemic lupus erythematosus. | ||
Smith LW, Gelber AC, Petri M. J Clin Rheumatol. 2013;19(7):397-9. |
||
The differential diagnosis of lymphadenopathy relevant to rheumatologists includes Kikuchi histiocytic necrotizing lymphadenitis, Castleman disease, syphilis, tuberculosis, sarcoidosis, and lymphoma. | ||
21940235 |
MALE | Middle Aged |
Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: review and speculations about pathogenesis. | ||
Haque M, Hou JS, Hisamichi K, Tamada K, Cusack CA, Abdelmalek M, Brown RE, Vonderheid EC. Clin Lymphoma Myeloma Leuk. 2011;11(6):453-61. |
||
Cutaneous and systemic plasmacytosis (C/SP), human herpes virus-8 (HHV8), negative multicentric plasmacytic Castleman disease (MPCD), and idiopathic plasmacytic lymphadenopathy are polyclonal plasma cell proliferations of unknown etiology that predominantly affect Asian individuals. | ||
19670534 |
MALE | Child |
Poems syndrome--a rare variant of plasma cell dyscrasia. Case report and review of literature. | ||
Goranova-Marinova VS, Chernev KG, Goranov SE. Folia Med (Plovdiv). 2009;51(2):5-11. |
||
We present a case of POEMS syndrome in a 47-year-old male patient who initially presented with edema of the lower limbs, moderate lymphadenopathy, hepatosplenomegaly, histological findings of Castleman disease with marked sinusoidal angioproliferation in the lymph nodes and multiple osteosclerotic lesions. | ||
9628975 |
MIXED_SAMPLE | Adult |
[Kikuchi's disease and proteinaceous lymphoadenopathy in 4 patients with HIV infection]. | ||
Cossu A, Lissia A, Cossu S, Marras V, Tanda F, Massarelli G. Pathologica. 1998;90(1):20-6. |
||
In the lymphadenopathy occurring in the acquired immunodeficiency syndrome (AIDS) and the AIDS related complex (ARC), consistent histologic patterns have been described with some variants thereof, such as angioimmunoblastic lymphadenopathy-like or Castleman disease-like. |